Robert Gailus

Bob is an experienced venture investor and advisor. He was a founding member of Schroder Ventures/U.S., the venture affiliate of Schroders, the London merchant bank. Bob has invested in more than 75 early-stage companies, including Celgene, Cell Therapeutics, Incyte Pharmaceuticals, and Neurogen. He founded Software Technology Venture Partners (“STVP”) in NYC, New York to invest in and advise IT companies in the Boston to NYC corridor. He joined with Bob Levenson, a successful entrepreneur and Fortune 500 operating executive (ADP, Medco and First Data Corp.), and formed LENOX Capital Group, LLC, to invest in early-stage technology and service companies. Bob is a former member of the New York Angels, and has been the Venture Advisor to OgdenCAP in New York City since 2007. Bob holds a BA from Columbia College (Academic All-American) and an MBA from Columbia University.